CSI Market
Sign In | Register

Progyny Inc (PGNY) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access PGNY Annual Cash Flow →
This cash flow overview for Progyny Inc spans from Jun 30 2025 to Jun 30 2026, illustrating how cash generation and usage have shifted across recent reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income52.28
Depreciation & amortization3.11
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed10.18
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment-0.58
Share-based Compensation40.20
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest0.60
Non Cash Interest Income Expense-
Non Cash Interest Expense Income0.28
Income taxes0.00
Marketable Securities, Realized Gain (Loss), Excluding Other than Temporary Impairments, Total-0.57
Increase (Decrease) in Accounts Receivable47.39
Increase (Decrease) in Accounts Payable27.84
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities7.98
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-3.81
Other Working Capital3.24
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-91.48
Discontinued operations0.00
Net Cash flow from Operating Activities96.37
Investing Activities
Capital Expenditures-12.57
Sale of Capital Items0.00
Proceeds from Sale of Available-for-sale Securities, Debt112.71
Payments to Acquire Available-for-sale Securities, Debt0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities100.15
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-147.93
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-7.55
Other net-0.53
Proceeds From Issuance Of Convertible Preferred Stock And Warrants Net-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents114.19
Restricted Cash And Cash Equivalents-
Restricted Cash Current1.04
Restricted Cash Noncurrent0.93
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-156.01
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow83.81
Total Cash Flow40.41
4 historic quarters locked

Sign in to unlock the full Progyny Inc cash flow history.

Sign In Create Free Account

About Progyny Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001551306-26-000140

Figures are derived from filed reports and may be restated. Historical data is subject to revision.